login
Current Deals

company details

PHILIPS INDIA LIMITED

  • www.philips.co.in
  • Sector: Healthcare
  • CHRYSEUM SCORE: 8.00/10.00
    ×

    PHILIPS INDIA LIMITED

    • Sector: Healthcare
    • CHRYSEUM SCORE: 8.00/10.00

    Description: Philips India Limited is a subsidiary of Royal Philips of the Netherlands, a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care.

    Evaluation is basis the latest financial year disclosures filed by the company

    Valuation

    Max Score: 3.50

    P/E of Company

    21.10

    AVG P/E of Key Peer/s

    42.11

    Valuation Score

    3.50

    The Valuation Score depicts if the company is available at a discount when compared to its listed/unlisted peers. Higher the discount, more is the score given to the company.

    Growth

    Max Score: 3.50

    Sales Growth

    2.43%

    PAT Growth

    1.71%

    ROE

    17.29%

    Growth Score

    1.50

    The Growth Score accounts for the growth in Sales and PAT on a 3 year CAGR basis and the Company’s ROE as per the latest financial year results released by the company.

    Leverage

    Max Score: 1.50

    Debt / Equity

    0.00

    AVG Industry Debt / Equity

    0.00

    Leverage Score

    1.50

    Lower the Debt/Equity, higher the score.

    Management Quality

    Max Score: 1.50

    Board Structure & Composition

    1.00

    Related Party Transactions

    1.00

    Timely Disclosure

    1.00

    Management Score

    1.50

    This score represents a consolidated view of the Company’s Management Quality, which includes Board Structure, Related Party Transactions and Timely disclosures. Each parameter is scored out of 1.

₹940.00 0.00 (0.00%)

As on 18 Apr, 2025
L 910.00 52 Week Range H 990.00
Company Description : A subsidiary of Royal Philips of the Netherlands a leading health technology company focused on enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care.
Company Overview
  • Name of Company PHILIPS INDIA LIMITED
  • Sector Healthcare
  • ISIN INE319A01016
  • Scrip Code PHILIPS INDIA
  • CIN U31902WB1930PLC006663
  • Pan No AABCP9487A
  • Face Value 10
  • Price ₹ 940.00
  • No. of Shares outstanding 5.75 Cr.
  • Market Cap ₹ 5,406.62 Cr
Financials
  • Revenue from operations ₹ 6,000.40 Cr.
  • EBITDA ₹ 508.30 Cr.
  • EBITDA Margin % 8.47%
  • Profit After Tax ₹ 257.50 Cr.
  • PAT Margin % 4.25%
  • EPS 44.78
  • Stock P/E 20.99
  • Book Value Per Share 258.98
  • P/B 3.63
  • Debt/Equity 0.00
Other Key Statistics
  • 52 week High/Low 990.00/910.00
  • Dividend Per Share 0.00
  • Dividend Yield 0.00%
  • Sales Growth - 3 years 2.43%
  • EBITDA Growth - 3 years -0.29%
  • PAT Growth - 3 years 1.71%
  • EPS Growth - 3 years 1.71%
  • ROE 17.29%
  • ROCE 15.57%
  • Cash Equivalents 272.80
All figures below are in INR Crores unless otherwise stated

Peer Comparison

Key Financials - FY24
Company Name Philips India Siemens Ltd
Listing Status Unlisted Listed
Revenue from Operations 6,000.40 20,987.80
Total Income 6,061.30 21,255.80
Finance Cost 38.80 43.90
Depreciation & Amortization 142.60 324.70
Total Expenses 5,734.40 18,883.50
EBITDA 508.30 2,740.90
PAT 257.50 2,336.00
No. of Shares Outstanding 5.75 35.61
EPS (in ₹) 44.78 65.60
Share Capital 57.50 71.20
Total Net Worth 1,489.60 13,095.70
Total Assets 3,915.70 90,033.70
Total Debt 0.00 0.00
Key Metrics:
CMP* 940.00 2,810.00
Market Cap (In Cr.) 5,406.62 100,064.10
Market Cap/Sales 0.89 4.71
EPS (Earnings Per Share) 44.78 65.60
BVPS (Book Value Per Share) 258.98 367.73
P/E 20.99 42.84
P/BV 3.63 7.64
EBITDA Margin 8.47% 13.06%
ROE 17.29% 17.84%
ROA 6.58% 2.59%
*Market Price in ₹ as on 18 Apr, 2025

Profit Loss

FY24 FY23 FY22 FY21 FY20
Revenue from operations 6,000.40 5,734.00 5,481.40 5,583.90 5,194.50
Y-o-Y Revenue Growth 4.65% 4.61% -1.84% 7.50% 5.75%
Other Income 60.90 71.90 64.80 55.50 58.90
Total Income 6,061.30 5,805.90 5,546.20 5,639.40 5,253.40
Total Expenses (Excludes Interest and Depreciation) 5,553.00 5,330.20 5,147.30 5,126.60 4,805.80
Operating Profit (After deducting Depreciation) 304.80 275.30 195.70 313.30 261.40
OPM % 5.08 4.80 3.57 5.61 5.03
EBITDA 508.30 475.70 398.90 512.80 447.60
Depreciation 142.60 128.50 138.40 144.00 127.30
EBIT 365.70 347.20 260.50 368.80 320.30
Interest 38.80 26.40 27.20 27.20 21.70
EBT before Exceptional Items 326.90 320.80 233.30 341.60 298.60
Prior period/Exceptional /Extra Ordinary Items 0.00 0.00 -130.90 21.60 -14.20
Profit before tax/EBT 326.90 320.80 364.20 320.00 312.80
Tax 69.40 60.80 98.30 75.30 169.10
Net Profit 257.50 260.00 265.90 244.70 143.70
Profit (loss) of minority interest 0.00 0.00 0.00 0.00 0.00
Total profit (loss) for period 257.50 260.00 265.90 244.70 143.70
EPS in Rs 44.78 45.21 46.23 42.56 24.99
EPS Change % -0.95% -2.21% 8.62% 70.31% -24.62%
EBITDA Change % 6.85% 19.25% -22.21% 14.57% -5.67%
Profit growth -0.96% -2.22% 8.66% 70.29% -24.65%
ROCE 15.57% 20.42% 9.42% 12.71% 12.73%
ROE 17.29% 21.06% 11.68% 10.23% 7.00%
Debt / Equity Ratio 0.00 0.00 0.00 0.00 0.00
Sales growth 3Years 2.43% 3.35%
Sales growth 5Years 4.08%
Dividend per share 0.00 222.00 3.00

Balance Sheet

FY24 FY23 FY22 FY21 FY20
Share Capital 57.50 57.50 57.50 57.50 57.50
Reserves 1,432.10 1,176.80 2,220.00 2,334.50 1,994.70
Total shareholders' funds 1,489.60 1,234.30 2,277.50 2,392.00 2,052.20
Borrowings 0.00 0.00 0.00 0.00 0.00
Other Liabilities 327.90 313.50 257.40 785.80 469.50
Total Liabilities 2,426.10 2,005.80 2,067.40 2,014.40 1,699.00
Fixed Assets 943.10 386.00 344.10 476.50 409.50
Capital WIP 24.90 115.80 26.90 41.40 24.70
Investments 4.70 5.00 5.30 0.00 0.00
Other Assets 369.20 445.30 862.90 1,876.40 880.90
Total Assets 3,915.70 3,240.10 4,344.90 4,406.40 3,751.20
Cash Equivalents 272.80 211.80 1,315.90 931.30 857.80
Total Current liability 1,567.50 1,540.10 1,579.90 1,505.40 1,235.90
Total Assets -Total Current liabilty 2,348.20 1,700.00 2,765.00 2,901.00 2,515.30

Cash Flow

FY24 FY23 FY22 FY21 FY20
Net Cash from / (used in) Operating Activity 735.50 341.30 131.70 826.10 251.00
Net Cash from / (used in) Investing Activity -582.90 -52.90 368.20 -234.30 -37.70
Net Cash from / (used in) Financing Activity -91.70 -1,392.50 -115.30 -99.70 -109.20
Net Inc/Dec In Cash And Cash Equivalents 61.00 -1,104.10 384.60 492.20 104.10

Share Holding Pattern

No. of Shares in Crs. % Holding
Promoters 5.53 96.13%
Non Promoters 0.22 3.87%

News

© 2022 Chryseum Advisors LLP. All rights reserved. LLPIN – AAD-0626

+91 98925 31672 | info@chryseum.in

For latest updates

Linkedin-in